Ethnic inequalities in older adults bowel cancer awareness: findings from a community survey conducted in an ethnically diverse region in England.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
16 03 2021
Historique:
received: 04 12 2020
accepted: 28 02 2021
entrez: 17 3 2021
pubmed: 18 3 2021
medline: 22 5 2021
Statut: epublish

Résumé

To date, research exploring the public's awareness of bowel cancer has taken place with predominantly white populations. To enhance our understanding of how bowel cancer awareness varies between ethnic groups, and inform the development of targeted interventions, we conducted a questionnaire study across three ethnically diverse regions in Greater London, England. Data were collected using an adapted version of the bowel cancer awareness measure. Eligible adults were individuals, aged 60+ years, who were eligible for screening. Participants were recruited and surveyed, verbally, by staff working at 40 community pharmacies in Northwest London, the Harrow Somali association, and St. Mark's Bowel Cancer Screening Centre. Associations between risk factor, symptom and screening awareness scores and ethnicity were assessed using multivariate regression. 1013 adults, aged 60+ years, completed the questionnaire; half were of a Black, Asian or Minority ethnic group background (n = 507; 50.0%). Participants recognised a mean average of 4.27 of 9 symptoms and 3.99 of 10 risk factors. Symptom awareness was significantly lower among all ethnic minority groups (all p's < 0.05), while risk factor awareness was lower for Afro-Caribbean and Somali adults, specifically (both p's < 0.05). One in three adults (n = 722; 29.7%) did not know there is a Bowel Cancer Screening Programme. Bowel screening awareness was particularly low among Afro-Caribbean and Somali adults (both p's < 0.05). Awareness of bowel cancer symptoms, risk factors and screening varies by ethnicity. Interventions should be targeted towards specific groups for whom awareness of screening and risk factors is low.

Sections du résumé

BACKGROUND
To date, research exploring the public's awareness of bowel cancer has taken place with predominantly white populations. To enhance our understanding of how bowel cancer awareness varies between ethnic groups, and inform the development of targeted interventions, we conducted a questionnaire study across three ethnically diverse regions in Greater London, England.
METHODS
Data were collected using an adapted version of the bowel cancer awareness measure. Eligible adults were individuals, aged 60+ years, who were eligible for screening. Participants were recruited and surveyed, verbally, by staff working at 40 community pharmacies in Northwest London, the Harrow Somali association, and St. Mark's Bowel Cancer Screening Centre. Associations between risk factor, symptom and screening awareness scores and ethnicity were assessed using multivariate regression.
RESULTS
1013 adults, aged 60+ years, completed the questionnaire; half were of a Black, Asian or Minority ethnic group background (n = 507; 50.0%). Participants recognised a mean average of 4.27 of 9 symptoms and 3.99 of 10 risk factors. Symptom awareness was significantly lower among all ethnic minority groups (all p's < 0.05), while risk factor awareness was lower for Afro-Caribbean and Somali adults, specifically (both p's < 0.05). One in three adults (n = 722; 29.7%) did not know there is a Bowel Cancer Screening Programme. Bowel screening awareness was particularly low among Afro-Caribbean and Somali adults (both p's < 0.05).
CONCLUSION
Awareness of bowel cancer symptoms, risk factors and screening varies by ethnicity. Interventions should be targeted towards specific groups for whom awareness of screening and risk factors is low.

Identifiants

pubmed: 33726716
doi: 10.1186/s12889-021-10536-y
pii: 10.1186/s12889-021-10536-y
pmc: PMC7967942
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

513

Subventions

Organisme : Cancer Research UK
ID : C68512/A28209
Pays : United Kingdom

Références

Gut. 2015 Oct;64(10):1637-49
pubmed: 26041752
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2127-31
pubmed: 21876191
Psychooncology. 2016 May;25(5):567-73
pubmed: 26358401
J Med Screen. 2019 Mar;26(1):3-10
pubmed: 30249158
BMC Cancer. 2011 Aug 23;11:366
pubmed: 21859500
BMJ Open. 2014 Aug 12;4(8):e005764
pubmed: 25116456
J Med Screen. 2019 Dec;26(4):169-178
pubmed: 31042098
Psychooncology. 2019 Dec;28(12):2336-2343
pubmed: 31509888
J Med Screen. 2010;17(3):125-31
pubmed: 20956722
Colorectal Dis. 2013 Aug;15(8):963-7
pubmed: 23656572
Int J Cancer. 2021 Mar 1;148(5):1172-1182
pubmed: 32875560
BMC Cancer. 2018 Sep 20;18(1):906
pubmed: 30236083
Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):720-6
pubmed: 25650183
Gut. 2012 Oct;61(10):1439-46
pubmed: 22156981
J Gen Intern Med. 2005 Feb;20(2):175-84
pubmed: 15836552
Eur J Cancer. 2018 Nov;103:267-273
pubmed: 30196989

Auteurs

Robert S Kerrison (RS)

Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK. Robert.kerrison.13@ucl.ac.uk.

Andrew Prentice (A)

St Mark's Bowel Cancer Screening Centre, St Mark's Hospital, Watford Road, Harrow, UK.

Sarah Marshall (S)

St Mark's Bowel Cancer Screening Centre, St Mark's Hospital, Watford Road, Harrow, UK.

Sameer Choglay (S)

St Mark's Bowel Cancer Screening Centre, St Mark's Hospital, Watford Road, Harrow, UK.
Public Health England, Skipton House, London, UK.

Michael Levitan (M)

The Middlesex Pharmaceutical Group of Local Pharmaceutical Committees, London, UK.

Marsha Alter (M)

The Middlesex Pharmaceutical Group of Local Pharmaceutical Committees, London, UK.

Alex Ghanouni (A)

Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK.

Lesley McGregor (L)

Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK.
Division of Psychology, University of Stirling, Stirling, UK.

Christian von Wagner (C)

Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK. C.Wagner@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH